Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
BCLI Quote, Financials, Valuation and Earnings
Last price:
$1.18
Seasonality move
:
53.36%
Day range:
$1.18 - $1.23
52-week range:
$0.72 - $6.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
219.5K
Avg. volume:
433.2K
1-year change:
-80.2%
Market cap:
$9.5M
Revenue:
--
EPS (TTM):
-$2.07
Earnings Data
Next earnings date for BCLI
Aug 14
2025
Most recent earnings per share
-$0.45
Beat by $0.52
(May 15/2025)
Consensus Estimate
-$0.97
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BCLI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.47 | -- |
| 08/14/2025 | Q2 | -- | -- | -- | -$0.33 | -- |
| 05/15/2025 | Q1 | -- | -- | -$0.45 | -$0.97 | $0.52 |
| 03/31/2025 | Q4 | -- | -- | -$0.51 | -$0.27 | -$0.24 |
| 11/14/2024 | Q3 | -- | -- | -$0.51 | -$0.70 | $0.19 |
| 08/14/2024 | Q2 | -- | -- | -$0.60 | -$0.45 | -$0.15 |
| 05/14/2024 | Q1 | -- | -- | -$0.75 | -- | -- |
| 03/29/2024 | Q4 | -- | -- | -$1.65 | -$1.65 | -- |
| 11/14/2023 | Q3 | -- | -- | -$0.45 | -$2.25 | $1.80 |
| 08/14/2023 | Q2 | -- | -- | -$1.95 | -$2.10 | $0.15 |
| 05/15/2023 | Q1 | -- | -- | -$2.10 | -- | -- |
| 03/30/2023 | Q4 | -- | -- | -$1.95 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$2.85 | -- | -- |
| 08/15/2022 | Q2 | -- | -- | -$2.85 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$2.25 | -- | -- |
| 03/28/2022 | Q4 | -- | -- | -$2.55 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$2.25 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$2.55 | -- | -- |
| 04/26/2021 | Q1 | -- | -- | -$2.85 | -- | -- |
| 02/03/2021 | Q4 | -- | -- | -$5.55 | -- | -- |
| 10/15/2020 | Q3 | -- | -- | -$2.10 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$3.75 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$4.80 | -- | -- |
| 02/17/2020 | Q4 | -- | -- | -$5.10 | -- | -- |
| 11/14/2019 | Q3 | -- | -- | -$3.75 | -- | -- |
| 08/13/2019 | Q2 | -- | -- | -$3.45 | -- | -- |
| 05/10/2019 | Q1 | -- | -- | -$3.60 | -- | -- |
| 03/29/2019 | Q4 | -- | -- | -$4.05 | -- | -- |
| 10/29/2018 | Q3 | -- | -- | -$2.25 | -- | -- |
| 07/23/2018 | Q2 | -- | -- | -$2.40 | -- | -- |
| 05/14/2018 | Q1 | -- | -- | -$1.80 | -- | -- |
| 03/08/2018 | Q4 | -- | -- | $0.30 | -- | -- |
| 10/17/2017 | Q3 | -- | -- | -$1.95 | -- | -- |
| 08/16/2017 | Q2 | -- | -- | -$0.90 | -- | -- |
| 05/15/2017 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/16/2017 | Q4 | -- | -- | -$0.60 | -- | -- |
| 11/15/2016 | Q3 | -- | -- | -$1.35 | -- | -- |
| 08/11/2016 | Q2 | -- | -- | -$0.75 | -- | -- |
| 05/12/2016 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/09/2016 | Q4 | -- | -- | -$1.05 | -- | -- |
| 11/19/2015 | Q3 | -- | -- | -$2.10 | -- | -- |
Brainstorm Cell Therapeutics Earnings Questions
-
How Much did Brainstorm Cell Therapeutics Generate in Revenue Last Quarter?
Brainstorm Cell Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Brainstorm Cell Therapeutics Beat Earnings Last Quarter?
Brainstorm Cell Therapeutics announced earnings per share of -$0.45 which represents a beat of analyst forecast a -$0.97 per share.
-
Is Brainstorm Cell Therapeutics Profitable?
Brainstorm Cell Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Brainstorm Cell Therapeutics EPS Next Year?
Brainstorm Cell Therapeutics's earnings are forecast to decrease from -$2.31 per share to -$2.10 per share next year representing a decrease of -30.74%.
-
When is Brainstorm Cell Therapeutics's Earnings Date?
Brainstorm Cell Therapeutics's next earnings date is August 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
